Mount Sinai is a recognized leader in neurological and cerebrovascular surgery, offering advanced treatments for brain tumors, spinal disorders, stroke, brain aneurysms, epilepsy and other neurological disorders. Empowered by the most advanced technologies available, the Department of Neurosurgery aspires to make a lasting, global impact in patient care, research, and outcomes. With passion, imagination, and visionary ideas, we are driving the next-generation treatments for neurosurgical care.
Founded in 1914, The Mount Sinai Hospital is ranked No. 14 by U.S. News & World Report in Neurology & Neurosurgery, 2015-16. Mount Sinai is the largest neurosurgery program in New York City with over 3,500 open surgical and 1,500 endovascular cases per year.
The Cerebrovascular Center at Mount Sinai is recognized as a leader in life-saving techniques for stroke, aneurysm, and intracerebral hemorrhage patients in New York and provides the highest quality treatments for vascular and related disorders of the brain, neck, and spine. Our multidisciplinary team of expert physicians – including Drs. J Mocco, Johanna Fifi, Reade De Leacy, Alejandro Berenstein and Joshua Bederson – are world renowned and have repeatedly been true pioneers in the treatment and research for aneurysms, carotid artery stenosis, tumors, hemangiomas, and vascular malformations.